At Everett Eye Care Center - https://lnkd.in/dT6PAYWD - Jessica S. Stone, O.D., provides a comfortable and modern eye care experience for her patients by bringing in the latest technologies available into her practice. She chooses MydCombi (tropicamide 1% and phenylephrine hydrochloride 2.5%) to dilate her patients. Learn how Eyenovia is making it possible by visiting https://bit.ly/3Dik87F #ophthalmology #optometry #eyenovia #optejet #drugdevice #technology #tech #investing #innovation #startups #mydcombi Contraindications: Known hypersensitivity to any component of the formulation. See Full Prescribing Information Here: https://bit.ly/4btbPHk
Eyenovia, Inc.’s Post
More Relevant Posts
-
#fundingalert 💼Company: Atraverse Medical, Inc. 💰Funding: $12.5Million ⚡Round: Seed 👥Investors: Physicians, reputable venture investors, and successful medtech entrepreneurs. Atraverse Medical is a medical device company pioneering next-generation left-heart access technology. The company’s proprietary HOTWIRE™ system, featuring universal sheath compatibility and optimized RF technology, aims to enhance outcomes and streamline workflows for physicians treating cardiovascular disease in millions of patients worldwide. The money will be used by the firm to further its early commercialization plans and increase its R&D activities. Atraverse Medical, led by CEO John Slump, announced that its HOTWIRETM radiofrequency (RF) guidewire has received FDA clearance. Steven Mickelsen , John Slump Read more - https://lnkd.in/gMNTAzFV To share your startup story write us on - contact@startuprise.io #AtraverseMedical #medicaldevicecompany #radiofrequency #commercialization #technology #funding #fundingnews #startup #startupnews #startuprise
To view or add a comment, sign in
-
SonoVascular is honored to have our SonoThrombectomy™ System featured as a “Standout” next-generation venous thrombectomy solution in the March 2024 issue of MedTech Strategist. Our team is excited to disrupt the venous thrombectomy space with our novel pharmaco-mechanical thrombectomy approach, driven by microbubble-mediated mechanical debulking of thrombus. We look forward to partnering with our world class scientific advisory board to bring this important technology forward and positively impact patients’ lives. Full MedTech Strategist article included in this post. #medtech #healthtech #medtechstartups #medtechinnovator
To view or add a comment, sign in
-
In the last few days, SamanTree Medical SA, Asceneuron SA, Regenosca SA, DemoSquare and Freesuns have raised several million Swiss Francs 🙌 Despite the uncertain times, Startupticker.ch's latest Swiss Venture Capital Report highlights the region's stability in terms of funding, which these new rounds demonstrate: - SamanTree Medical SA raises $14M to support global expansion and innovation in surgical treatment - Lausanne-based Asceneuron SA raises $100 million for its groundbreaking treatments of neurodegenerative diseases - Regenosca SA closes a CHF 1M pre-seed round for its non-invasive regenerative tissue implants - DemoSquare Closes CHF 1.2 Million Pre-Seed Round - CHF 1 million for Freesuns' solar roof tiles Patrick Barbey points out: "Vaud's innovative fabric continues to show its dynamism during this summer break, with several successive fundraisings, the majority in the life sciences sector. This is due to an ideal setting, with top-class laboratories and a rich academic network, combined with talented entrepreneurs, confirming a trend that has been in place for over ten years." Read more 👉 https://lnkd.in/di2EMDZ9 #VDTech #SwissTech
To view or add a comment, sign in
-
Metyos, a medtech startup founded by Alexandre Boulanger and Olga Chashchina, is pioneering the development of a biowearable aimed at monitoring chronic kidney disease (CKD). Their arm-worn patch is designed to track biomarkers associated with CKD, providing real-time data to both patients and healthcare professionals. In this clip, Paul Durand-Estèbe explains how crucial Altium 365 has been in the design of Metyos' electronics and the ways in which it is helping their company grow. The latest Altium Stories episode focusing on Metyos is out now: https://bit.ly/4bl9jCF #altiumstories #medicaltechnology #startup #innovation #wearabletech
To view or add a comment, sign in
-
#fundingalert 💼Company: Shape Memory Medical Inc. 💰Funding: $38Million ⚡Round: Series C 👥Investors: Earlybird Venture Capital, HBM Healthcare Investments AG , Emergent Medical Partners II LP, WexMed II LLC, HBM-Medfocus LLC. Shape Memory Medical Inc. is dedicated to developing innovative therapeutic solutions with its proprietary shape memory polymers, with devices approved in more than 25 countries spanning regions in #Asia, the Middle East, #Europe, the #Americas and #Australia. The #funds will support the execution of the AAA-SHAPE Pivotal Trial, a randomized controlled study comparing EVAR plus sac management with IMPEDE-FX RapidFill to stand-alone EVAR. The #funding will also support the research and #development of their product pipeline, and the expansion of sales and marketing strategies to address the increasing demand for their commercially-available IMPEDE Embolization Plug family of devices,” continued Ruppel. Thom Rasche Edward (Ted) Ruppel Anthony Lipp Mary Dennehy Meghan Reu Read more - https://lnkd.in/gpD_zSGk To share your startup story write us on - contact@startuprise.io #shapememorymedical #medicaldevice #innovation #innovationinhealthcare #funding #startup #news #enterpreneurship #healthtechstartup
To view or add a comment, sign in
-
Advice from those who've been there and done it is always helpful. Starting or scaling a business in Life Science or Tech? Have a look/listen.
Helping Leaders in Life Sciences find significant contributors delivering Leadership, Technical, Sales & BD who can grow with the business I MD @ Kleboe Jardine | Startup, Scale-up Search that Solves Problems
What founders of an early stage business in life sciences face in start up and scale up according to our recent CEO interviewees. Sarah Lynagh, Janet Downie, Jamie Blackport, Richard Boyd, Albert Nicholl, Jeremy Wheeler & Michael Roberts Fios Genomics, RoslinCT, Privacy Hub by Datavant, Invizius, BIOCAPTIVA LIMITED, Chromatin Bioscience, Carcinotech Ltd, Nami Surgical & Bioliberty Thanks again for your insights. #Startup #Scaleup #Lifesciences More to come on the channel so stay tuned.
To view or add a comment, sign in
-
MydCombi (tropicamide 1% and phenylephrine hydrochloride 2.5%) is now available nationwide! Introduce your patients to the experience of modern mydriasis by visiting EyenoviaRx. Start now: bit.ly/ERxNew Learn more about MydCombi: bit.ly/mydcombi #ophthalmology #optometry #eyenovia #optejet #drugdevice #technology #tech #investing #innovation #startups #mydcombi Contraindications: Known hypersensitivity to any component of the formulation. See Full Prescribing Information Here: bit.ly/4btbPHk
To view or add a comment, sign in
-
Breaking bones is unfortunately a common part of life; in fact doctors treat about 6.8 million fractures each year in the United States, and the average person can expect to sustain two fractures over their lifetime. In the latest episode of the #MedtechImpactPodcast, Kyle Kruse 🚀and I are joined by Brian Hess, CEO and Founder of RevBio, Inc., who is helping to transform bone repair with their innovative adhesive. Not only is this solution boosting how bones can rapidly fuse back together through its biomimicry properties, this is a product that stimulates bone growth and leaves no artifact in the body. From raising nearly $20 million in non-dilutive funding, it’s clear that this technology has huge potential with multiple indications available to be applied to. Brian lays out a clear strategic path to market that includes the opportunity to leverage early animal studies with veterinarians also seeing significant value from this exciting technology in the near term. Throughout this discussion, Brian displays all the attributes of a great leader. With a top co-founder coupled alongside in D. Grayson Allen, Brian shares how they have developed a winning culture, and a team that thrives on the opportunities they are given to both develop personally and help take this product to market. As a UMassM2D2 resident, RevBio is able to access a number of resources and an incredible pipeline of young talented interns who have grown with the company and stepped up into more senior roles. This is a startup story that is packed full of the hallmarks for building a successful innovative medical solution, and one that is sure to leave you informed and inspired. Look out for Brian if you're heading to LSI next week and would like to learn more about their exciting innovation. And if you're interested in joining RevBio at one of the world's leading medtech incubators here at M2D2, be sure to get in touch! https://lnkd.in/drZhga2T University of Massachusetts Lowell, Michael Brown, Molly Shutt, Brittany McDonough, Rahul Jadia Ph.D., Omega Funds, Sujit Tatke, Lisa Donnelly, Masha Dumanis, Scott Sigman MD, Gerald Hodgkinson, PhD, Justin Barbas, TOM GAMACHE, Mira Sahney, Lisa Donnelly, Rajit Kamal, Ibraheem Badejo, PhD, MLS, Sectoral Asset Management, Endeavour Vision, Amzak Capital Management, NFL Players Association #Medtech #Startups #KeepInnovating
To view or add a comment, sign in
-
Wishing Brian Hess and the RevBio, Inc. team the best as they gear up for the LSI USA 24' conference next week! It was a pleasure to host Brian on The MedTech Impact Podcast, where he shared their journey and talked about the orthopedic and dental problems they're looking to solve. A standout moment was learning about their inspiration from marine animals in creating Tetranite, a synthetic bone adhesive. Catch the entire episode on your favorite podcast platform or by clicking the link in the comments section! - 🚀 #medicaldevice #medicaldevices #orthopedics #orthopedicsurgery #dental #dentistry
Breaking bones is unfortunately a common part of life; in fact doctors treat about 6.8 million fractures each year in the United States, and the average person can expect to sustain two fractures over their lifetime. In the latest episode of the #MedtechImpactPodcast, Kyle Kruse 🚀and I are joined by Brian Hess, CEO and Founder of RevBio, Inc., who is helping to transform bone repair with their innovative adhesive. Not only is this solution boosting how bones can rapidly fuse back together through its biomimicry properties, this is a product that stimulates bone growth and leaves no artifact in the body. From raising nearly $20 million in non-dilutive funding, it’s clear that this technology has huge potential with multiple indications available to be applied to. Brian lays out a clear strategic path to market that includes the opportunity to leverage early animal studies with veterinarians also seeing significant value from this exciting technology in the near term. Throughout this discussion, Brian displays all the attributes of a great leader. With a top co-founder coupled alongside in D. Grayson Allen, Brian shares how they have developed a winning culture, and a team that thrives on the opportunities they are given to both develop personally and help take this product to market. As a UMassM2D2 resident, RevBio is able to access a number of resources and an incredible pipeline of young talented interns who have grown with the company and stepped up into more senior roles. This is a startup story that is packed full of the hallmarks for building a successful innovative medical solution, and one that is sure to leave you informed and inspired. Look out for Brian if you're heading to LSI next week and would like to learn more about their exciting innovation. And if you're interested in joining RevBio at one of the world's leading medtech incubators here at M2D2, be sure to get in touch! https://lnkd.in/drZhga2T University of Massachusetts Lowell, Michael Brown, Molly Shutt, Brittany McDonough, Rahul Jadia Ph.D., Omega Funds, Sujit Tatke, Lisa Donnelly, Masha Dumanis, Scott Sigman MD, Gerald Hodgkinson, PhD, Justin Barbas, TOM GAMACHE, Mira Sahney, Lisa Donnelly, Rajit Kamal, Ibraheem Badejo, PhD, MLS, Sectoral Asset Management, Endeavour Vision, Amzak Capital Management, NFL Players Association #Medtech #Startups #KeepInnovating
To view or add a comment, sign in
-
🌟#StartupSpotlight: Get to know our amazing residents at our high-tech incubator! 🌟This week, we're shining the spotlight on Lifelight Health GmbH! ❗ Did you know that targeted drug delivery systems offer a promising approach to improving treatment outcomes? Unlike, for example, traditional chemotherapy, which can have systemic side effects, delivering medication directly to the affected site, enhances effectiveness while reducing damage to healthy tissue - exactly the goal of Lifelight Health! Lifelight Health is developing innovative implantable medical devices for the targeted release of biologicals and small molecules without the need for injection. The system is based on a novel linker system that enables an actively controlled, precise and rapid release of approved drugs. This kind of localized therapy allows highly effective treatment of hard-to-reach targets, such as brain tumours, while minimizing side effects for patients. Curious about who's in our current batch? Check out our website and learn more about our startups & incubation programme! https://lnkd.in/eEnDKGsv Simon Blazy Oliver Plettenburg #StartupSpotlight #BioIntelligence #HighTechIncubator #Biotech #Lifesciences #InnovationHub #IncubatorLife #StartupEcosystem #Entrepreneurship #StartupCommunity #StartupJourney #StartupLife
To view or add a comment, sign in
7,073 followers